GBV-C/Hepatitis G virus (GBV-C/HGV) is a newly discovered viral agent, foun
d widely among healthy blood donors and among individuals at risk of parent
erally transmitted infections. GBV-C/HGV is found frequently in coinfection
with HCV. A population of 109 HCV positive patients was examined for the p
resence of GBV-C/HGV RNA and antibodies to E2. Of the 109 patients, 23 (21%
) had serum GBV-C/HGV RNA in serum, 39 (36%) had only antibodies to E2 and
8 (7%) were positive for both markers, with an overall prevalence of 64%. D
ifferent serologic and virological patterns were observed in GBV-C/HGV expo
sed patients according to their infection status. Active infection was char
acterized by positive RT/PCR signal with primers for both the 5'UTR and NS5
genomic regions, viremia levels above 10(4) copies/mL by real time quantit
ative RT/PCR and absence of detectable anti-E2. In the transition phase bet
ween active infection and recovery, GBV-C/HGV RNA was only detectable by RT
/PCR using primers from the 5' untranslated region and viremia levels were
below 10(4) copies/ml by quantitative PCR, with or without simultaneous pre
sence of anti-E2 antibodies. Resolved infection was characterized by absenc
e of detectable viremia and, in most patients, by the presence of anti-E2.
(C) 1999 Wiley-Liss, Inc.